Terumo Aortic
Medical Equipment ManufacturingScotland, United Kingdom501-1000 Employees
Terumo Aortic is a medical equipment manufacturer based in Newmains, Scotland, United Kingdom, and operates as a subsidiary of Terumo Corporation. The company employs between 501 and 1,000 people and develops aortic care solutions, delivering a broad portfolio of implantable devices and digital technologies that can be personalized for patients. Its portfolio includes devices for complex aortic disease, including the fenestrated TREO abdominal stent-graft system, which has been designated a Breakthrough Device by the U.S. FDA. Terumo Aortic has received multiple awards, including King’s Awards for Innovation and for Voluntary Service, and eight Queen’s Awards for Enterprise, with recognitions announced in 2026; the company also expanded its facilities to Glasgow. The company reports revenue in the range of $100 million to $250 million.